CAT N°: 14618
Price:

From 75.00 63.75

CNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 ?M for AMPA and kainate receptors, respectively, versus IC50 = 25 ?M for NMDA receptors).{23071,23072} This compound has been used to specifically target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,2,3,4-tetrahydro-7-nitro-2,3-dioxo-6-quinoxalinecarbonitrile
  • Correlated keywords
    • FG 9065 FG9065 FGs 9065 NMDA n methyl-D-aspartate non-NMDA glutamates receptors antagonists AMPA kainites neurosciences signals transductions synaptic transmissions ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acids responses 6-cyano-7-nitroquinoxaline-2,3-dione 6 7 cyano nitroquinoxalines 2 3 diones CNQX alpha aminos hydroxyl 5 methyls 4 isoxazolepropionic competitive non AMPA
  • Product Overview:
    CNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 ?M for AMPA and kainate receptors, respectively, versus IC50 = 25 ?M for NMDA receptors).{23071,23072} This compound has been used to specifically target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors.

We also advise you